查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1873626

牛黄：全球市场份额和排名、总收入和需求预测（2025-2031 年）

Calculus Bovis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 104 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024 年全球胃石市场规模估计为 1.75 亿美元，预计在预测期（2025-2031 年）内将以 15.8% 的复合年增长率增长，到 2031 年将调整至 5.04 亿美元。

本报告对近期关税调整和国际战略反制措施对牛胆石（牛黄）跨境产业布局、资本配置模式、区域经济相互依存关係和供应链重组的影响进行了全面评估。

这些结石是传统中医中使用的牛胆结石。在中国和日本等国家，牛胆结石长期以来被用于治疗各种疾病，包括高烧、抽搐和中风。在亚洲国家，牛胆结石有时会在屠宰时收集。这些结石是牛（一种属于脊索动物门的哺乳动物）的干燥牛。在胆囊中形成的结石称为“胆结石”或“肝结石”，在胆管中形成的结石称为“胆结石”，在肝管中形成的结石称为“肝黄”。完整的结石主要呈椭圆形，质地轻盈，表面光滑，呈金黄色至黄褐色。在中医中，牛胆结石被描述为具有清香、微苦微甘的味道，并具有清凉的功效。它们用于退烧、解毒和镇静神经。内服可治疗高烧、昏迷、躁症、儿童痉挛症和抽搐，外用可治疗咽喉痛、口腔炎、痈和中毒。

天然石材极为稀少，无法工业化生产，因此本报告将重点介绍两种主要类型的产品：试管内培育石材和人造石材。

全球领先的胃石生产商包括建民集团、迪博药业、明兴药业、仁齐药业、红茂药业和同仁堂。前五大企业总合占80%的市场份额，其中建民集团产量最大，占20%。全球胃石生产主要集中在中国，中国消费量约占全球市场的90%。依产品类型，胃石分为试管内培养胃石和人工胃石，前者市占率高达75%。依应用领域划分，医药领域是最大的应用领域，市占率达95%，其次是中药领域。

肾结石市场的主要驱动因素包括：

1. 资源稀缺：天然琥珀供应受到严重限制

生产瓶颈

病因：胆结石是病理产物。只有0.1-0.2%的牛胆结石能够自发性形成，且其形成週期较长（3-5年）。

2. 政策法规：产业准入法规和标准升级

生产许可证管理

在中国，只有六家公司（包括建民集团和同仁堂）被允许生产天然琥珀，每年的配额不到 800 公斤。

2025 年版《中国药典》将提高琥珀含量的检测标准，将杂质的上限从 2% 收紧至 0.5%，迫使企业优化其采购和加工技术。

3. 高端消费：高端中医的需求正在快速成长。

草药学领域

安米亚牛黄丸：核心成分牛黄占10%，年需求量超过200吨，推动牛黄使用量成长15%。

片彩帆：天然羚羊角製品单价超过1,000元/片，销量较去年同期成长20%。

拓展至保健食品及化妆品领域

牛胆牙膏：含微量牛胆，单价是一般牙膏的五倍，市占率每年成长 25%。

抗衰老产品：在高端护肤中使用方解石萃取物，目标客户群预计将以 30% 的复合年增长率成长。

4. 技术替代方案：琥珀体外培养的技术突破

工业化进程加速

武汉建民大鹏药业已实现试管培养牛黄的大规模生产，年产能达5吨，而成本仅为天然牛黄的十分之一。

功效检验：国家食品药物管理局已核准该产品作为天然石头的替代品用于42种中成药中，覆盖了80%的石头製剂。

市场渗透率提高

虽然人工养殖的羚羊角占据了中低价价格分布市场 60% 以上的份额，从而降低了对天然羚羊角的需求，但在高端市场，人工养殖的羚羊角仍然难以被取代。

5. 资本主导：产业链整合与金融化

垄断上游资源

片子黄和同仁堂透过拥有海外牧场保障了牛供应。

期货和衍生

羚羊角期货在亳州中药交易所上市交易，年交易量超过50亿元。价格发现机制有助于降低企业的采购风险。

6. 文化信仰：传统医学观念根深蒂固

草药的地位不可动摇。

在《神农本草经》中，留根被描述为上品，其作为中医理论中「寒水三宝」之首的地位，加深了消费者的认可。

它已成为一件很有价值的礼物。

天然牛黄製品已成为高端礼品，单价超过10万元的牛黄工艺品年销售额超过10亿元。

7. 挑战与解决方案

永续供应问题

对策：推广试管内培养技术，开发合成生物学途径生产石英，减少对自然资源的依赖。

价格波动风险

对策：建立国家战略储备制度，加强期货市场的避险方法，平滑企业的成本曲线。

琥珀市场是资源稀缺、政策限制、日益精细化的消费和技术替代等因素协同作用的典型例证。展望未来，该产业将呈现「高品质天然琥珀、大规模养殖技术、产业链金融化」的三重发展趋势。企业必须透过技术创新、资源垄断和文化行销，在供应限制和需求激增之间寻求平衡，主导未来十年市场结构的变革。

本报告旨在按地区/国家、类型和应用对全球牛黄市场进行全面分析，重点关注总销售量、收入、价格、市场份额和主要企业的排名。

本报告以销售量（公斤）和收入（百万美元）为单位，对牛黄市场规模、估算和预测进行了呈现，以2024年为基准年，并涵盖了2020年至2031年的历史数据和预测数据。定量和定性分析将帮助读者制定牛黄业务和成长策略，评估市场竞争，分析自身在当前市场中的地位，并做出明智的商业决策。

市场区隔

公司

  • Jianmin Group
  • Dibo Pharmaceuticals
  • Ming Hing Pharmaceutical
  • Renqi Pharmaceutical
  • Hongmao Pharmaceutical
  • Tongrentang

按类型分類的细分市场

  • 人造石
  • 体外培养的结石

应用领域

  • 配药
  • 草药

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Calculus Bovis was estimated to be worth US$ 175 million in 2024 and is forecast to a readjusted size of US$ 504 million by 2031 with a CAGR of 15.8% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Calculus Bovis cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Bezoar is a bovine gallstone used in traditional Chinese medicine. In countries such as China and Japan, it has long been used to treat a variety of diseases, including high fever, convulsions and stroke. In Asian countries, cattle stones are sometimes harvested when cattle are slaughtered. Bezoar is a dried gallstone of cattle, a mammal of the phylum Chordata. Those produced in the gallbladder are called "bile yellow" or "egg yolk", those produced in the bile duct are called "tube yellow", and those produced in the hepatic duct are called "liver yellow". The complete bezoar is mostly oval in shape, light in texture, with a golden to yellow-brown surface, delicate and shiny. Traditional Chinese medicine believes that bezoar has a fresh fragrance, a slightly bitter taste and then sweet, and a cool nature. It can be used to relieve fever, detoxify, and calm the nerves. It can be taken internally to treat high fever, coma, mania, infantile convulsions, convulsions, etc. It can be used externally to treat sore throat, mouth sores, carbuncle, and toxicity.

Because natural bezoar is extremely rare and cannot be produced industrially. Therefore, this report mainly counts two types of products: in vitro cultivated bezoar and artificial bezoar.

The global key manufacturers of calculus bovis include Jianmin Group, Dibo Pharmaceuticals, Mingxing Pharmaceuticals, Renqi Pharmaceuticals, Hongmao Pharmaceuticals, and Tongrentang. The top five manufacturers together account for 80% of the market share, with Jianmin Group being the largest producer with 20% of the market share. The global origin is mainly concentrated in China. At the consumer level, China holds close to 90% of the market share. In terms of product category, it is divided into in vitro calculus bovis and artificial bezoar, with the former having a higher market share of 75%. In terms of its application,preparations medicine is its top application area with 95% market share, followed by Chinese hebal medicine.

The driving factors of the bezoar market mainly include

1. Resource scarcity: rigid constraints on the supply of natural bezoar

Production bottleneck

Cause: Bezoar is a pathological product. Only 0.1%-0.2% of cattle gallstones can form natural bezoar, and the breeding cycle is long (requires 3-5 years).

2. Policy control: industry access and standard upgrade

Production license control

China only allows 6 companies (such as Jianmin Group and Tongrentang) to produce natural bezoar, and implements a quota system with an annual quota of less than 800 kilograms.

The 2025 edition of the "Chinese Pharmacopoeia" raises the detection standard for bezoar content, and the impurity limit is tightened from 2% to 0.5%, forcing companies to optimize procurement and processing technology.

3. Consumption upgrade: Demand for high-end Chinese medicine explodes

Chinese patent medicine field

Angong Niuhuang Wan: The core raw material bezoar accounts for 10%, and the annual demand exceeds 200 tons, driving the use of bezoar to increase by 15%.

Pianzaihuang: The unit price of natural bezoar formula products exceeds 1,000 yuan/tablet, and sales increase by 20% year-on-year.

Health products and cosmeceuticals extension

Bezoar toothpaste: adding trace amounts of bezoar ingredients, the unit price is 5 times that of ordinary toothpaste, and the market share increases by 25% annually.

Anti-aging products: bezoar extract is used for high-end skin care, and the target customer group CAGR reaches 30%.

4. Technology substitution: breakthrough in in vitro cultivation of bezoar

Industrialization process is accelerated

Wuhan Jianmin Dapeng Pharmaceutical has achieved large-scale production of in vitro cultivated bezoar, with a cost of only 1/10 of natural bezoar and an annual production capacity of 5 tons.

Efficacy verification: The State Food and Drug Administration has approved it to replace natural bezoar for 42 kinds of Chinese patent medicines, covering 80% of bezoar preparations.

Market penetration rate increases

In vitro cultivated bezoar has a market share of more than 60% in the low- and medium-end markets, squeezing out the demand for natural bezoar, but it is still irreplaceable in the high-end field.

5. Capital drive: industrial chain integration and financialization

Upstream resource monopoly

Pianzihuang and Tongrentang lock in cattle sources by holding overseas ranches.

Futures and financial derivatives

Bezoar futures are listed on the Bozhou Chinese Medicine Exchange, with an annual trading volume of over 5 billion yuan. The price discovery function reduces corporate procurement risks.

6. Cultural beliefs: Traditional medical cognition is solidified

The status of the pharmacopoeia is unshakable

The "Shennong Bencao Jing" lists bezoar as a top-grade product, and its status as the first of the "three treasures of cold water" in traditional Chinese medicine theory deepens consumer cognition.

Gift attributes are strengthened

Natural bezoar products have become high-end gifts, and the annual sales of bezoar handicrafts with a unit price of more than 100,000 yuan exceeds 1 billion yuan.

7. Challenges and coping strategies

Sustainable supply problems

Countermeasures: Promote in vitro cultivation technology, develop synthetic biology pathways for bezoar, and reduce dependence on natural resources.

Price volatility risk

Countermeasures: Establish a national strategic reserve system, improve hedging tools in the futures market, and smooth the cost curve of enterprises.

The bezoar market is a typical scenario of resource scarcity, policy control, consumption upgrades and technological substitution resonance. In the future, the industry will present the triple trends of "high-end natural bezoar, large-scale in vitro cultivation, and financialization of the industrial chain." Enterprises need to seek a balance between supply constraints and demand explosion through technological breakthroughs, resource monopoly and cultural marketing, and dominate the market structure in the next decade.

This report aims to provide a comprehensive presentation of the global market for Calculus Bovis, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Calculus Bovis by region & country, by Type, and by Application.

The Calculus Bovis market size, estimations, and forecasts are provided in terms of sales volume (kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Calculus Bovis.

Market Segmentation

By Company

  • Jianmin Group
  • Dibo Pharmaceuticals
  • Ming Hing Pharmaceutical
  • Renqi Pharmaceutical
  • Hongmao Pharmaceutical
  • Tongrentang

Segment by Type

  • Artificial Bezoar
  • In Vitro Cultured Bezoar

Segment by Application

  • Preparations Medicine
  • Chinese Herbal Medicine

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Calculus Bovis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Calculus Bovis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Calculus Bovis in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Calculus Bovis Product Introduction
  • 1.2 Global Calculus Bovis Market Size Forecast
    • 1.2.1 Global Calculus Bovis Sales Value (2020-2031)
    • 1.2.2 Global Calculus Bovis Sales Volume (2020-2031)
    • 1.2.3 Global Calculus Bovis Sales Price (2020-2031)
  • 1.3 Calculus Bovis Market Trends & Drivers
    • 1.3.1 Calculus Bovis Industry Trends
    • 1.3.2 Calculus Bovis Market Drivers & Opportunity
    • 1.3.3 Calculus Bovis Market Challenges
    • 1.3.4 Calculus Bovis Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Calculus Bovis Players Revenue Ranking (2024)
  • 2.2 Global Calculus Bovis Revenue by Company (2020-2025)
  • 2.3 Global Calculus Bovis Players Sales Volume Ranking (2024)
  • 2.4 Global Calculus Bovis Sales Volume by Company Players (2020-2025)
  • 2.5 Global Calculus Bovis Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Calculus Bovis Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Calculus Bovis Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Calculus Bovis
  • 2.9 Calculus Bovis Market Competitive Analysis
    • 2.9.1 Calculus Bovis Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Calculus Bovis Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Calculus Bovis as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Artificial Bezoar
    • 3.1.2 In Vitro Cultured Bezoar
  • 3.2 Global Calculus Bovis Sales Value by Type
    • 3.2.1 Global Calculus Bovis Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Calculus Bovis Sales Value, by Type (2020-2031)
    • 3.2.3 Global Calculus Bovis Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Calculus Bovis Sales Volume by Type
    • 3.3.1 Global Calculus Bovis Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Calculus Bovis Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Calculus Bovis Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Calculus Bovis Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Preparations Medicine
    • 4.1.2 Chinese Herbal Medicine
  • 4.2 Global Calculus Bovis Sales Value by Application
    • 4.2.1 Global Calculus Bovis Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Calculus Bovis Sales Value, by Application (2020-2031)
    • 4.2.3 Global Calculus Bovis Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Calculus Bovis Sales Volume by Application
    • 4.3.1 Global Calculus Bovis Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Calculus Bovis Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Calculus Bovis Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Calculus Bovis Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Calculus Bovis Sales Value by Region
    • 5.1.1 Global Calculus Bovis Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Calculus Bovis Sales Value by Region (2020-2025)
    • 5.1.3 Global Calculus Bovis Sales Value by Region (2026-2031)
    • 5.1.4 Global Calculus Bovis Sales Value by Region (%), (2020-2031)
  • 5.2 Global Calculus Bovis Sales Volume by Region
    • 5.2.1 Global Calculus Bovis Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Calculus Bovis Sales Volume by Region (2020-2025)
    • 5.2.3 Global Calculus Bovis Sales Volume by Region (2026-2031)
    • 5.2.4 Global Calculus Bovis Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Calculus Bovis Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Calculus Bovis Sales Value, 2020-2031
    • 5.4.2 North America Calculus Bovis Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Calculus Bovis Sales Value, 2020-2031
    • 5.5.2 Europe Calculus Bovis Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Calculus Bovis Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Calculus Bovis Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Calculus Bovis Sales Value, 2020-2031
    • 5.7.2 South America Calculus Bovis Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Calculus Bovis Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Calculus Bovis Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Calculus Bovis Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Calculus Bovis Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Calculus Bovis Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Calculus Bovis Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Calculus Bovis Sales Value, 2020-2031
    • 6.3.2 United States Calculus Bovis Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Calculus Bovis Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Calculus Bovis Sales Value, 2020-2031
    • 6.4.2 Europe Calculus Bovis Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Calculus Bovis Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Calculus Bovis Sales Value, 2020-2031
    • 6.5.2 China Calculus Bovis Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Calculus Bovis Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Calculus Bovis Sales Value, 2020-2031
    • 6.6.2 Japan Calculus Bovis Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Calculus Bovis Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Calculus Bovis Sales Value, 2020-2031
    • 6.7.2 South Korea Calculus Bovis Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Calculus Bovis Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Calculus Bovis Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Calculus Bovis Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Calculus Bovis Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Calculus Bovis Sales Value, 2020-2031
    • 6.9.2 India Calculus Bovis Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Calculus Bovis Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Jianmin Group
    • 7.1.1 Jianmin Group Company Information
    • 7.1.2 Jianmin Group Introduction and Business Overview
    • 7.1.3 Jianmin Group Calculus Bovis Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Jianmin Group Calculus Bovis Product Offerings
    • 7.1.5 Jianmin Group Recent Development
  • 7.2 Dibo Pharmaceuticals
    • 7.2.1 Dibo Pharmaceuticals Company Information
    • 7.2.2 Dibo Pharmaceuticals Introduction and Business Overview
    • 7.2.3 Dibo Pharmaceuticals Calculus Bovis Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Dibo Pharmaceuticals Calculus Bovis Product Offerings
    • 7.2.5 Dibo Pharmaceuticals Recent Development
  • 7.3 Ming Hing Pharmaceutical
    • 7.3.1 Ming Hing Pharmaceutical Company Information
    • 7.3.2 Ming Hing Pharmaceutical Introduction and Business Overview
    • 7.3.3 Ming Hing Pharmaceutical Calculus Bovis Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Ming Hing Pharmaceutical Calculus Bovis Product Offerings
    • 7.3.5 Ming Hing Pharmaceutical Recent Development
  • 7.4 Renqi Pharmaceutical
    • 7.4.1 Renqi Pharmaceutical Company Information
    • 7.4.2 Renqi Pharmaceutical Introduction and Business Overview
    • 7.4.3 Renqi Pharmaceutical Calculus Bovis Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Renqi Pharmaceutical Calculus Bovis Product Offerings
    • 7.4.5 Renqi Pharmaceutical Recent Development
  • 7.5 Hongmao Pharmaceutical
    • 7.5.1 Hongmao Pharmaceutical Company Information
    • 7.5.2 Hongmao Pharmaceutical Introduction and Business Overview
    • 7.5.3 Hongmao Pharmaceutical Calculus Bovis Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Hongmao Pharmaceutical Calculus Bovis Product Offerings
    • 7.5.5 Hongmao Pharmaceutical Recent Development
  • 7.6 Tongrentang
    • 7.6.1 Tongrentang Company Information
    • 7.6.2 Tongrentang Introduction and Business Overview
    • 7.6.3 Tongrentang Calculus Bovis Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Tongrentang Calculus Bovis Product Offerings
    • 7.6.5 Tongrentang Recent Development

8 Industry Chain Analysis

  • 8.1 Calculus Bovis Industrial Chain
  • 8.2 Calculus Bovis Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Calculus Bovis Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Calculus Bovis Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Calculus Bovis Market Trends
  • Table 2. Calculus Bovis Market Drivers & Opportunity
  • Table 3. Calculus Bovis Market Challenges
  • Table 4. Calculus Bovis Market Restraints
  • Table 5. Global Calculus Bovis Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Calculus Bovis Revenue Market Share by Company (2020-2025)
  • Table 7. Global Calculus Bovis Sales Volume by Company (2020-2025) & (kg)
  • Table 8. Global Calculus Bovis Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Calculus Bovis Price by Company (2020-2025) & (US$/kg)
  • Table 10. Key Manufacturers Calculus Bovis Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Calculus Bovis Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Calculus Bovis
  • Table 13. Global Calculus Bovis Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Calculus Bovis as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Calculus Bovis Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Calculus Bovis Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Calculus Bovis Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Calculus Bovis Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Calculus Bovis Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Calculus Bovis Sales Volume by Type: 2020 VS 2024 VS 2031 (kg)
  • Table 22. Global Calculus Bovis Sales Volume by Type (2020-2025) & (kg)
  • Table 23. Global Calculus Bovis Sales Volume by Type (2026-2031) & (kg)
  • Table 24. Global Calculus Bovis Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Calculus Bovis Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Calculus Bovis Price by Type (2020-2025) & (US$/kg)
  • Table 27. Global Calculus Bovis Price by Type (2026-2031) & (US$/kg)
  • Table 28. Global Calculus Bovis Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Calculus Bovis Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Calculus Bovis Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Calculus Bovis Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Calculus Bovis Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Calculus Bovis Sales Volume by Application: 2020 VS 2024 VS 2031 (kg)
  • Table 34. Global Calculus Bovis Sales Volume by Application (2020-2025) & (kg)
  • Table 35. Global Calculus Bovis Sales Volume by Application (2026-2031) & (kg)
  • Table 36. Global Calculus Bovis Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Calculus Bovis Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Calculus Bovis Price by Application (2020-2025) & (US$/kg)
  • Table 39. Global Calculus Bovis Price by Application (2026-2031) & (US$/kg)
  • Table 40. Global Calculus Bovis Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Calculus Bovis Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Calculus Bovis Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Calculus Bovis Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Calculus Bovis Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Calculus Bovis Sales Volume by Region (kg): 2020 VS 2024 VS 2031
  • Table 46. Global Calculus Bovis Sales Volume by Region (2020-2025) & (kg)
  • Table 47. Global Calculus Bovis Sales Volume by Region (2026-2031) & (kg)
  • Table 48. Global Calculus Bovis Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Calculus Bovis Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Calculus Bovis Average Price by Region (2020-2025) & (US$/kg)
  • Table 51. Global Calculus Bovis Average Price by Region (2026-2031) & (US$/kg)
  • Table 52. Key Countries/Regions Calculus Bovis Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Calculus Bovis Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Calculus Bovis Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Calculus Bovis Sales Volume, (2020-2025) & (kg)
  • Table 56. Key Countries/Regions Calculus Bovis Sales Volume, (2026-2031) & (kg)
  • Table 57. Jianmin Group Company Information
  • Table 58. Jianmin Group Introduction and Business Overview
  • Table 59. Jianmin Group Calculus Bovis Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 60. Jianmin Group Calculus Bovis Product Offerings
  • Table 61. Jianmin Group Recent Development
  • Table 62. Dibo Pharmaceuticals Company Information
  • Table 63. Dibo Pharmaceuticals Introduction and Business Overview
  • Table 64. Dibo Pharmaceuticals Calculus Bovis Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 65. Dibo Pharmaceuticals Calculus Bovis Product Offerings
  • Table 66. Dibo Pharmaceuticals Recent Development
  • Table 67. Ming Hing Pharmaceutical Company Information
  • Table 68. Ming Hing Pharmaceutical Introduction and Business Overview
  • Table 69. Ming Hing Pharmaceutical Calculus Bovis Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 70. Ming Hing Pharmaceutical Calculus Bovis Product Offerings
  • Table 71. Ming Hing Pharmaceutical Recent Development
  • Table 72. Renqi Pharmaceutical Company Information
  • Table 73. Renqi Pharmaceutical Introduction and Business Overview
  • Table 74. Renqi Pharmaceutical Calculus Bovis Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 75. Renqi Pharmaceutical Calculus Bovis Product Offerings
  • Table 76. Renqi Pharmaceutical Recent Development
  • Table 77. Hongmao Pharmaceutical Company Information
  • Table 78. Hongmao Pharmaceutical Introduction and Business Overview
  • Table 79. Hongmao Pharmaceutical Calculus Bovis Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 80. Hongmao Pharmaceutical Calculus Bovis Product Offerings
  • Table 81. Hongmao Pharmaceutical Recent Development
  • Table 82. Tongrentang Company Information
  • Table 83. Tongrentang Introduction and Business Overview
  • Table 84. Tongrentang Calculus Bovis Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 85. Tongrentang Calculus Bovis Product Offerings
  • Table 86. Tongrentang Recent Development
  • Table 87. Key Raw Materials Lists
  • Table 88. Raw Materials Key Suppliers Lists
  • Table 89. Calculus Bovis Downstream Customers
  • Table 90. Calculus Bovis Distributors List
  • Table 91. Research Programs/Design for This Report
  • Table 92. Key Data Information from Secondary Sources
  • Table 93. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Calculus Bovis Product Picture
  • Figure 2. Global Calculus Bovis Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Calculus Bovis Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Calculus Bovis Sales Volume (2020-2031) & (kg)
  • Figure 5. Global Calculus Bovis Sales Price (2020-2031) & (US$/kg)
  • Figure 6. Calculus Bovis Report Years Considered
  • Figure 7. Global Calculus Bovis Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Calculus Bovis Players Sales Volume Ranking (2024) & (kg)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Calculus Bovis Revenue in 2024
  • Figure 10. Calculus Bovis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Artificial Bezoar Picture
  • Figure 12. In Vitro Cultured Bezoar Picture
  • Figure 13. Global Calculus Bovis Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 14. Global Calculus Bovis Sales Value Market Share by Type, 2024 & 2031
  • Figure 15. Global Calculus Bovis Sales Volume by Type (2020 VS 2024 VS 2031) & (kg)
  • Figure 16. Global Calculus Bovis Sales Volume Market Share by Type, 2024 & 2031
  • Figure 17. Global Calculus Bovis Price by Type (2020-2031) & (US$/kg)
  • Figure 18. Product Picture of Preparations Medicine
  • Figure 19. Product Picture of Chinese Herbal Medicine
  • Figure 20. Global Calculus Bovis Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 21. Global Calculus Bovis Sales Value Market Share by Application, 2024 & 2031
  • Figure 22. Global Calculus Bovis Sales Volume by Application (2020 VS 2024 VS 2031) & (kg)
  • Figure 23. Global Calculus Bovis Sales Volume Market Share by Application, 2024 & 2031
  • Figure 24. Global Calculus Bovis Price by Application (2020-2031) & (US$/kg)
  • Figure 25. North America Calculus Bovis Sales Value (2020-2031) & (US$ Million)
  • Figure 26. North America Calculus Bovis Sales Value by Country (%), 2024 VS 2031
  • Figure 27. Europe Calculus Bovis Sales Value, (2020-2031) & (US$ Million)
  • Figure 28. Europe Calculus Bovis Sales Value by Country (%), 2024 VS 2031
  • Figure 29. Asia Pacific Calculus Bovis Sales Value, (2020-2031) & (US$ Million)
  • Figure 30. Asia Pacific Calculus Bovis Sales Value by Region (%), 2024 VS 2031
  • Figure 31. South America Calculus Bovis Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. South America Calculus Bovis Sales Value by Country (%), 2024 VS 2031
  • Figure 33. Middle East & Africa Calculus Bovis Sales Value, (2020-2031) & (US$ Million)
  • Figure 34. Middle East & Africa Calculus Bovis Sales Value by Country (%), 2024 VS 2031
  • Figure 35. Key Countries/Regions Calculus Bovis Sales Value (%), (2020-2031)
  • Figure 36. Key Countries/Regions Calculus Bovis Sales Volume (%), (2020-2031)
  • Figure 37. United States Calculus Bovis Sales Value, (2020-2031) & (US$ Million)
  • Figure 38. United States Calculus Bovis Sales Value by Type (%), 2024 VS 2031
  • Figure 39. United States Calculus Bovis Sales Value by Application (%), 2024 VS 2031
  • Figure 40. Europe Calculus Bovis Sales Value, (2020-2031) & (US$ Million)
  • Figure 41. Europe Calculus Bovis Sales Value by Type (%), 2024 VS 2031
  • Figure 42. Europe Calculus Bovis Sales Value by Application (%), 2024 VS 2031
  • Figure 43. China Calculus Bovis Sales Value, (2020-2031) & (US$ Million)
  • Figure 44. China Calculus Bovis Sales Value by Type (%), 2024 VS 2031
  • Figure 45. China Calculus Bovis Sales Value by Application (%), 2024 VS 2031
  • Figure 46. Japan Calculus Bovis Sales Value, (2020-2031) & (US$ Million)
  • Figure 47. Japan Calculus Bovis Sales Value by Type (%), 2024 VS 2031
  • Figure 48. Japan Calculus Bovis Sales Value by Application (%), 2024 VS 2031
  • Figure 49. South Korea Calculus Bovis Sales Value, (2020-2031) & (US$ Million)
  • Figure 50. South Korea Calculus Bovis Sales Value by Type (%), 2024 VS 2031
  • Figure 51. South Korea Calculus Bovis Sales Value by Application (%), 2024 VS 2031
  • Figure 52. Southeast Asia Calculus Bovis Sales Value, (2020-2031) & (US$ Million)
  • Figure 53. Southeast Asia Calculus Bovis Sales Value by Type (%), 2024 VS 2031
  • Figure 54. Southeast Asia Calculus Bovis Sales Value by Application (%), 2024 VS 2031
  • Figure 55. India Calculus Bovis Sales Value, (2020-2031) & (US$ Million)
  • Figure 56. India Calculus Bovis Sales Value by Type (%), 2024 VS 2031
  • Figure 57. India Calculus Bovis Sales Value by Application (%), 2024 VS 2031
  • Figure 58. Calculus Bovis Industrial Chain
  • Figure 59. Calculus Bovis Manufacturing Cost Structure
  • Figure 60. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 61. Bottom-up and Top-down Approaches for This Report
  • Figure 62. Data Triangulation
  • Figure 63. Key Executives Interviewed